Nephros Stock Technical Analysis
| NEPH Stock | USD 4.04 0.15 3.86% |
As of the 12th of February 2026, Nephros secures the Mean Deviation of 4.34, standard deviation of 6.14, and Risk Adjusted Performance of (0.02). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nephros, as well as the relationship between them.
Nephros Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Nephros, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to NephrosNephros' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Nephros Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 7.0 | Strong Buy | 2 | Odds |
Most Nephros analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Nephros stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Nephros, talking to its executives and customers, or listening to Nephros conference calls.
Is there potential for Household Appliances market expansion? Will Nephros introduce new products? Factors like these will boost the valuation of Nephros. Anticipated expansion of Nephros directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Nephros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.729 | Earnings Share 0.14 | Revenue Per Share | Quarterly Revenue Growth 0.354 | Return On Assets |
The market value of Nephros is measured differently than its book value, which is the value of Nephros that is recorded on the company's balance sheet. Investors also form their own opinion of Nephros' value that differs from its market value or its book value, called intrinsic value, which is Nephros' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Nephros' market value can be influenced by many factors that don't directly affect Nephros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Nephros' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Nephros should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Nephros' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Nephros 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nephros' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nephros.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in Nephros on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Nephros or generate 0.0% return on investment in Nephros over 90 days. Nephros is related to or competes with Daxor, Heartbeam, OneMedNet Corp, ImmuCell, OS Therapies, JIN MEDICAL, and OUTLOOK THERAPEUTICS. Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United St... More
Nephros Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nephros' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nephros upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 36.15 | |||
| Value At Risk | (7.71) | |||
| Potential Upside | 11.32 |
Nephros Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nephros' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nephros' standard deviation. In reality, there are many statistical measures that can use Nephros historical prices to predict the future Nephros' volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.94) | |||
| Treynor Ratio | 0.4735 |
Nephros February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | 0.4835 | |||
| Mean Deviation | 4.34 | |||
| Coefficient Of Variation | (3,018) | |||
| Standard Deviation | 6.14 | |||
| Variance | 37.66 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.94) | |||
| Treynor Ratio | 0.4735 | |||
| Maximum Drawdown | 36.15 | |||
| Value At Risk | (7.71) | |||
| Potential Upside | 11.32 | |||
| Skewness | 1.23 | |||
| Kurtosis | 3.13 |
Nephros Backtested Returns
Nephros is risky at the moment. Nephros has Sharpe Ratio of close to zero, which conveys that the firm had a close to zero % return per unit of risk over the last 3 months. We have found twenty-two technical indicators for Nephros, which you can use to evaluate the volatility of the firm. Please verify Nephros' Standard Deviation of 6.14, risk adjusted performance of (0.02), and Mean Deviation of 4.34 to check out if the risk estimate we provide is consistent with the expected return of 0.0356%. The company secures a Beta (Market Risk) of -0.45, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Nephros are expected to decrease at a much lower rate. During the bear market, Nephros is likely to outperform the market. Nephros right now secures a risk of 6.15%. Please verify Nephros skewness, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Nephros will be following its current price movements.
Auto-correlation | 0.19 |
Very weak predictability
Nephros has very weak predictability. Overlapping area represents the amount of predictability between Nephros time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nephros price movement. The serial correlation of 0.19 indicates that over 19.0% of current Nephros price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.19 | |
| Spearman Rank Test | 0.24 | |
| Residual Average | 0.0 | |
| Price Variance | 0.13 |
Nephros technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Nephros Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Nephros across different markets.
About Nephros Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Nephros on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Nephros based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Nephros price pattern first instead of the macroeconomic environment surrounding Nephros. By analyzing Nephros's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Nephros's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Nephros specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Dividend Yield | 0.011 | 0.0144 | Price To Sales Ratio | 1.26 | 1.19 |
Nephros February 12, 2026 Technical Indicators
Most technical analysis of Nephros help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Nephros from various momentum indicators to cycle indicators. When you analyze Nephros charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | 0.4835 | |||
| Mean Deviation | 4.34 | |||
| Coefficient Of Variation | (3,018) | |||
| Standard Deviation | 6.14 | |||
| Variance | 37.66 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.94) | |||
| Treynor Ratio | 0.4735 | |||
| Maximum Drawdown | 36.15 | |||
| Value At Risk | (7.71) | |||
| Potential Upside | 11.32 | |||
| Skewness | 1.23 | |||
| Kurtosis | 3.13 |
Nephros February 12, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Nephros stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 1,425 | ||
| Daily Balance Of Power | 0.71 | ||
| Rate Of Daily Change | 1.04 | ||
| Day Median Price | 4.00 | ||
| Day Typical Price | 4.01 | ||
| Price Action Indicator | 0.12 |
Complementary Tools for Nephros Stock analysis
When running Nephros' price analysis, check to measure Nephros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nephros is operating at the current time. Most of Nephros' value examination focuses on studying past and present price action to predict the probability of Nephros' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nephros' price. Additionally, you may evaluate how the addition of Nephros to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |